Schizophrenia: one lot of paliperidone extended-release recalled

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Teva Pharmaceuticals has issued a recall of a single lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A, expiration 6/2018, NDC 0591-3693-19.

Why this matters

  • The lot failed a dissolution test, which could result in less drug absorbance and reduced efficacy.

Key points

  • Teva Pharmaceuticals USA initially recalled the lot ...